Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Diosmectite
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
Details : Smecta (Diosmectite) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diarrhea.
Product Name : Smecta
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 08, 2017
Lead Product(s) : Diosmectite
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diosmectite
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults
Details : Smecta is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diarrhea.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 09, 2016
Lead Product(s) : Diosmectite
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable